Who are low immunogenic interferon-beta-1a's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): PegIFN-2b.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/low-immunogenic-interferon-beta-1a.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

low immunogenic interferon-beta-1a — Competitive Intelligence Brief

low immunogenic interferon-beta-1a (low immunogenic interferon-beta-1a) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Interferon-beta. Area: Immunology.

marketed Interferon-beta Interferon-beta receptor (IFNAR) Immunology Small molecule Live · refreshed every 30 min

Target snapshot

low immunogenic interferon-beta-1a (low immunogenic interferon-beta-1a) — Biogen. Low immunogenic interferon-beta-1a activates interferon-beta signaling pathways to modulate immune responses and reduce inflammation in autoimmune diseases.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
low immunogenic interferon-beta-1a TARGET	low immunogenic interferon-beta-1a	Biogen	marketed	Interferon-beta	Interferon-beta receptor (IFNAR)
PegIFN-2b	PegIFN-2b	Merck Sharp & Dohme LLC	marketed	Pegylated interferon-beta	Interferon-beta receptor (IFNAR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Interferon-beta class)

Biogen · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). low immunogenic interferon-beta-1a — Competitive Intelligence Brief. https://druglandscape.com/ci/low-immunogenic-interferon-beta-1a. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab